Drug intelligence / Profile preview

propamidine

Development stage
Unknown
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Propamidine is a small molecule aromatic diamidine compound with antiseptic and disinfectant properties. It acts as an antimicrobial agent, exhibiting bacteriostatic activity against a wide range of organisms, including pyrogenic cocci, antibiotic-resistant staphylococci, and some Gram-negative bacilli. Propamidine retains its antibacterial activity in the presence of organic matter such as tissue fluids, pus, and serum. The most commonly used form clinically is the salt propamidine isethionate (formed with isethionic acid), which is primarily indicated for minor eye or eyelid infections such as conjunctivitis and blepharitis, as well as for Acanthamoeba infections (notably keratitis). Its mechanism involves disruption of microbial cell processes; studies suggest it may inhibit melanin biosynthesis in fungi and increase chitin content in fungal cell walls[3][4][8]. It also acts by stopping bacterial growth to allow host immune clearance[7].

Brand names
Brolene
Other names
propamidinapropamidine isethionatepropamidine diisethionatepropamidine isetionatepropamidine isthionate
02

Targets

THNR (1,3,8-Trihydroxynaphthalene reductase)

Beyond the preview

Go deeper on propamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propamidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call